Extracellular matrix proteomics identifies molecular signature of symptomatic carotid plaques
Open accessThe DOI matches its Crossref record; 83 of the 85 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The identification of patients with high-risk atherosclerotic plaques prior to the manifestation of clinical events remains challenging. Recent findings question histology- and imaging-based definitions of the "vulnerable plaque," necessitating an improved approach for predicting onset of symptoms. METHODS: We performed a proteomics comparison of the vascular extracellular matrix and associated molecules in human carotid endarterectomy specimens from 6 symptomatic versus 6 asymptomatic patients to identify a protein signature for high-risk atherosclerotic plaques. Proteomics data were integrated with gene expression profiling of 121 carotid endarterectomies and an analysis of protein secretion by lipid-loaded human vascular smooth muscle cells. Finally, epidemiological validation of candidate biomarkers was performed in two community-based studies. RESULTS: Proteomics and at least one of the other two approaches identified a molecular signature of plaques from symptomatic patients that comprised matrix metalloproteinase 9, chitinase 3-like-1, S100 calcium binding protein A8 (S100A8), S100A9, cathepsin B, fibronectin, and galectin-3-binding protein. Biomarker candidates measured in 685 subjects in the Bruneck study were associated with progression to advanced atherosclerosis and incidence of cardiovascular disease over a 10-year follow-up period. A 4-biomarker signature (matrix metalloproteinase 9, S100A8/S100A9, cathepsin D, and galectin-3-binding protein) improved risk prediction and was successfully replicated in an independent cohort, the SAPHIR study. CONCLUSION: The identified 4-biomarker signature may improve risk prediction and diagnostics for the management of cardiovascular disease. Further, our study highlights the strength of tissue-based proteomics for biomarker discovery. FUNDING: UK: British Heart Foundation (BHF); King's BHF Center; and the National Institute for Health Research Biomedical Research Center based at Guy's and St Thomas' NHS Foundation Trust and King's College London in partnership with King's College Hospital. Austria: Federal Ministry for Transport, Innovation and Technology (BMVIT); Federal Ministry of Science, Research and Economy (BMWFW); Wirtschaftsagentur Wien; and Standortagentur Tirol.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Proteomic studies have also addressed the kilometres of vascular beds and extracellular matrix responsible for transporting blood, giving valuable insights into the molecular anatomy of aneurysms and atherosclerosis126,127.”
From A high-stringency blueprint of the human proteome (2020) · cites this paper as [127]
Experimental — accuracy not yet measuredIn the citing paper
“Further evidence that VSMCs are the major source of collagens comes from studies in vitro , including proteomic analysis of the secretome of lipid-loaded VSMCs 109 and induction of collagen synthesis by VSMCs in culture by TGFβ , PDGF, IL-1, AngII, cholesterol, homocysteine and mechanical stretch 144,145”
From Vascular smooth muscle cells in atherosclerosis (2019) · cites this paper as [109]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DeLong, E. R., DeLong, D. M., & Clarke-Pearson, D. L. (1988) · Biometrics · doi:10.2307/2531595 · Cited by 22,649
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,338
Mass Spectrometric Sequencing of Proteins from Silver-Stained Polyacrylamide Gels
Shevchenko, A., Wilm, M., Vorm, O., & Mann, M. (1996) · Analytical Chemistry · doi:10.1021/ac950914h · Cited by 8,995
Inflammation, Atherosclerosis, and Coronary Artery Disease
Hansson, G. K. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043430 · Cited by 8,773 · cited 1×
“org Volume 127 Number 4 April 2017 Introduction Atherosclerosis is a chronic and progressive disease of the arterial wall and the main underlying cause of stroke, myocardial infarction (MI), and cardiac death (1, 2).”
Pencina, M. J., D' Agostino, R. B., D' Agostino, R. B., & Vasan, R. S. (2008) · Statistics in Medicine · doi:10.1002/sim.2929 · Cited by 6,493 · cited 3×
“Using the 10-year risk categories 5%, 5% to 7.5%, and ≥7.5%, the categorical net reclassification improvement (NRI) (80) was calculated.”
InfluentialReport of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1183 · Cited by 6,220
Assessing the Performance of Prediction Models: A Framework for Traditional and Novel Measures
Steyerberg, E. W., Vickers, A. J., Cook, N. R., Gerds, T., Gonen, M., Obuchowski, N., Pencina, M. J., & Kattan, M. W. (2010) · Epidemiology · doi:10.1097/ede.0b013e3181c30fb2 · Cited by 5,170
Keller, A., Nesvizhskii, A. I., Kolker, E., & Aebersold, R. (2002) · Analytical Chemistry · doi:10.1021/ac025747h · Cited by 4,830
A Statistical Model for Identifying Proteins by Tandem Mass Spectrometry
Nesvizhskii, A. I., Keller, A., Kolker, E., & Aebersold, R. (2003) · Analytical Chemistry · doi:10.1021/ac0341261 · Cited by 4,809
Remodelling the extracellular matrix in development and disease
Bonnans, C., Chou, J., & Werb, Z. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3904 · Cited by 4,367 · cited 2×
“The vascular ECM is crucial for the structural organization and integrity of the artery wall (7, 8).”
Progress and challenges in translating the biology of atherosclerosis
Libby, P., Ridker, P. M., & Hansson, G. K. (2011) · Nature · doi:10.1038/nature10146 · Cited by 4,010 · cited 1×
“Atherosclerosis is a chronic and progressive disease of the arterial wall and the main underlying cause of stroke, myocardial infarction (MI), and cardiac death (1, 2).”
A Prospective Natural-History Study of Coronary Atherosclerosis
Stone, G. W., Maehara, A., Lansky, A. J., de Bruyne, B., Cristea, E., Mintz, G. S., Mehran, R., McPherson, J., Farhat, N., Marso, S. P., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1002358 · Cited by 3,276
Danesh, J., Wheeler, J. G., Hirschfield, G. M., Eda, S., Eiriksdottir, G., Rumley, A., Lowe, G. D. O., Pepys, M. B., & Gudnason, V. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032804 · Cited by 2,953
Galis, Z. S., Sukhova, G. K., Lark, M. W., & Libby, P. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117619 · Cited by 2,539
Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers
Pencina, M. J., D'Agostino, R. B., & Steyerberg, E. W. (2011) · Statistics in Medicine · doi:10.1002/sim.4085 · Cited by 2,453
Assarsson, E., Lundberg, M., Holmquist, G., Björkesten, J., Bucht Thorsen, S., Ekman, D., Eriksson, A., Rennel Dickens, E., Ohlsson, S., Edfeldt, G., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095192 · Cited by 1,874
Urban, C. F., Ermert, D., Schmid, M., Abu-Abed, U., Goosmann, C., Nacken, W., Brinkmann, V., Jungblut, P. R., & Zychlinsky, A. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000639 · Cited by 1,673
WEB-based GEne SeT AnaLysis Toolkit (WebGestalt): update 2013
Wang, J., Duncan, D., Shi, Z., & Zhang, B. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt439 · Cited by 1,498
A case-cohort design for epidemiologic cohort studies and disease prevention trials
PRENTICE, R. L. (1986) · Biometrika · doi:10.1093/biomet/73.1.1 · Cited by 1,439
Mechanisms of Acute Coronary Syndromes and Their Implications for Therapy
Libby, P. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1216063 · Cited by 1,262
Shankman, L. S., Gomez, D., Cherepanova, O. A., Salmon, M., Alencar, G. F., Haskins, R. M., Swiatlowska, P., Newman, A. A. C., Greene, E. S., Straub, A. C., et al. (2015) · Nature Medicine · doi:10.1038/nm.3866 · Cited by 1,218
Toll-like Receptor 4 Polymorphisms and Atherogenesis
Kiechl, S., Lorenz, E., Reindl, M., Wiedermann, C. J., Oberhollenzer, F., Bonora, E., Willeit, J., & Schwartz, D. A. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012673 · Cited by 1,024
Self-citationHalliday, A., Harrison, M., Hayter, E., Kong, X., Mansfield, A., Marro, J., Pan, H., Peto, R., Potter, J., Rahimi, K., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61197-x · Cited by 942
Reynolds, J. L., Joannides, A. J., Skepper, J. N., McNair, R., Schurgers, L. J., Proudfoot, D., Jahnen-Dechent, W., Weissberg, P. L., & Shanahan, C. M. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000141960.01035.28 · Cited by 911
Self-citationShankman, L. S., Gomez, D., Cherepanova, O. A., Salmon, M., Alencar, G. F., Haskins, R. M., Swiatlowska, P., Newman, A. A. C., Greene, E. S., Straub, A. C., et al. (2016) · Nature Medicine · doi:10.1038/nm0216-217a · Cited by 764
Blankenberg, S., Rupprecht, H. J., Poirier, O., Bickel, C., Smieja, M., Hafner, G., Meyer, J., Cambien, F., & Tiret, L. (2003) · Circulation · doi:10.1161/01.cir.0000058700.41738.12 · Cited by 755
Distribution of macrophage polarization markers in human atherosclerosis
Stöger, J. L., Gijbels, M. J. J., van der Velden, S., Manca, M., van der Loos, C. M., Biessen, E. A. L., Daemen, M. J. A. P., Lutgens, E., & de Winther, M. P. J. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.09.013 · Cited by 621
Diboun, I., Wernisch, L., Orengo, C. A., & Koltzenburg, M. (2006) · BMC Genomics · doi:10.1186/1471-2164-7-252 · Cited by 592
Hyperglycemia Promotes Myelopoiesis and Impairs the Resolution of Atherosclerosis
Nagareddy, P. R., Murphy, A. J., Stirzaker, R. A., Hu, Y., Yu, S., Miller, R. G., Ramkhelawon, B., Distel, E., Westerterp, M., Huang, L.-S., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.04.001 · Cited by 577
Stegemann, C., Pechlaner, R., Willeit, P., Langley, S. R., Mangino, M., Mayr, U., Menni, C., Moayyeri, A., Santer, P., Rungger, G., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.002500 · Cited by 564
Self-citationThe National Survey of Stroke. Clinical findings.
Walker, A., Robins, M., & Weinfeld, F. D. (1981) · PubMed · Cited by 460
Groves, W. E., Davis, F. C., & Sells, B. H. (1968) · Analytical Biochemistry · doi:10.1016/0003-2697(68)90307-2 · Cited by 449
The Myth of the “Vulnerable Plaque”
Arbab-Zadeh, A., & Fuster, V. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.11.041 · Cited by 434
Lysosomal Cysteine Proteases in Atherosclerosis
Liu, J., Sukhova, G. K., Sun, J.-S., Xu, W.-H., Libby, P., & Shi, G.-P. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000134530.27208.41 · Cited by 393
Healy, A. M., Pickard, M. D., Pradhan, A. D., Wang, Y., Chen, Z., Croce, K., Sakuma, M., Shi, C., Zago, A. C., Garasic, J., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.607333 · Cited by 334
Ionita, M. G., van den Borne, P., Catanzariti, L. M., Moll, F. L., de Vries, J.-P. P. M., Pasterkamp, G., Vink, A., & de Kleijn, D. P. V. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.209296 · Cited by 302
Self-citationRequiem for the ‘vulnerable plaque’
Libby, P., & Pasterkamp, G. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv349 · Cited by 295
Self-citationProteomics Characterization of Extracellular Space Components in the Human Aorta
Didangelos, A., Yin, X., Mandal, K., Baumert, M., Jahangiri, M., & Mayr, M. (2010) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m110.001693 · Cited by 287
Self-citationDidangelos, A., Yin, X., Mandal, K., Saje, A., Smith, A., Xu, Q., Jahangiri, M., & Mayr, M. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.008128 · Cited by 285
Self-citationKiechl, S., Wittmann, J., Giaccari, A., Knoflach, M., Willeit, P., Bozec, A., Moschen, A. R., Muscogiuri, G., Sorice, G. P., Kireva, T., et al. (2013) · Nature Medicine · doi:10.1038/nm.3084 · Cited by 255
Self-citationSasaki, T. (1998) · The EMBO Journal · doi:10.1093/emboj/17.6.1606 · Cited by 245
miR-24 limits aortic vascular inflammation and murine abdominal aneurysm development
Maegdefessel, L., Spin, J. M., Raaz, U., Eken, S. M., Toh, R., Azuma, J., Adam, M., Nagakami, F., Heymann, H. M., Chernugobova, E., et al. (2014) · Nature Communications · doi:10.1038/ncomms6214 · Cited by 235
Koths, K., Taylor, E., Halenbeck, R., Casipit, C., & Wang, A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85233-x · Cited by 233
Comparative Lipidomics Profiling of Human Atherosclerotic Plaques
Stegemann, C., Drozdov, I., Shalhoub, J., Humphries, J., Ladroue, C., Didangelos, A., Baumert, M., Allen, M., Davies, A. H., Monaco, C., et al. (2011) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.110.959098 · Cited by 209
Self-citationThe Natural Course of Atherosclerosis: Part II: Vascular Remodeling
Kiechl, S., & Willeit, J. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.6.1491 · Cited by 207
Self-citationAltwegg, L. A., Neidhart, M., Hersberger, M., Muller, S., Eberli, F. R., Corti, R., Roffi, M., Sutsch, G., Gay, S., von Eckardstein, A., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm078 · Cited by 200
Sluijter, J. P. G., Pulskens, W. P. C., Schoneveld, A. H., Velema, E., Strijder, C. F., Moll, F., de Vries, J.-P., Verheijen, J., Hanemaaijer, R., de Kleijn, D. P. V., et al. (2006) · Stroke · doi:10.1161/01.str.0000196986.50059.e0 · Cited by 197
Self-citationNaylor, A. R., Rothwell, P. M., & Bell, P. R. F. (2003) · European Journal of Vascular and Endovascular Surgery · doi:10.1053/ejvs.2002.1946 · Cited by 196
Novel Candidate Genes in Unstable Areas of Human Atherosclerotic Plaques
Papaspyridonos, M., Smith, A., Burnand, K. G., Taylor, P., Padayachee, S., Suckling, K. E., James, C. H., Greaves, D. R., & Patel, L. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000229695.68416.76 · Cited by 193
The secreted tumor-associated antigen 90K is a potent immune stimulator
Ullrich, A., Sures, I., D'Egidio, M., Jallal, B., Powell, T. J., Herbst, R., Dreps, A., Azam, M., Rubinstein, M., & Natoli, C. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32322-0 · Cited by 191
The Natural Course of Atherosclerosis: Part I: Incidence and Progression
Kiechl, S., & Willeit, J. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.6.1484 · Cited by 186
Self-citationStatistical Similarities between Transcriptomics and Quantitative Shotgun Proteomics Data
Pavelka, N., Fournier, M. L., Swanson, S. K., Pelizzola, M., Ricciardi-Castagnoli, P., Florens, L., & Washburn, M. P. (2008) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m700240-mcp200 · Cited by 167
Kastrup, J., Johansen, J. S., Winkel, P., Hansen, J. F., Hildebrandt, P., Jensen, G. B., Jespersen, C. M., Kjoller, E., Kolmos, H. J., Lind, I., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp049 · Cited by 158
Gene expression signatures, pathways and networks in carotid atherosclerosis
Perisic, L., Aldi, S., Sun, Y., Folkersen, L., Razuvaev, A., Roy, J., Lengquist, M., Åkesson, S., Wheelock, C. E., Maegdefessel, L., et al. (2016) · Journal of Internal Medicine · doi:10.1111/joim.12448 · Cited by 149
Self-citationHakala, J. K., Oksjoki, R., Laine, P., Du, H., Grabowski, G. A., Kovanen, P. T., & Pentikäinen, M. O. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000077207.49221.06 · Cited by 137
Willeit, J., Kiechl, S., Oberhollenzer, F., Rungger, G., Egger, G., Bonora, E., Mitterer, M., & Muggeo, M. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.2.529 · Cited by 136
Self-citationThe role of galectin-3 and galectin-3–binding protein in venous thrombosis
DeRoo, E., Wrobleski, S. K., Shea, E. M., Al-Khalil, R., Hawley, A. E., Henke, P. K., Myers, D. D., Wakefield, T. W., & Diaz, J. A. (2014) · Blood · doi:10.1182/blood-2014-04-569939 · Cited by 119
de Kleijn, D. P. V., Moll, F. L., Hellings, W. E., Ozsarlak-Sozer, G., de Bruin, P., Doevendans, P. A., Vink, A., Catanzariti, L. M., Schoneveld, A. H., Algra, A., et al. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.194944 · Cited by 115
Self-citationCotoi, O. S., Dunér, P., Ko, N., Hedblad, B., Nilsson, J., Björkbacka, H., & Schiopu, A. (2014) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.113.302432 · Cited by 113
Ionita, M. G., Vink, A., Dijke, I. E., Laman, J. D., Peeters, W., van der Kraak, P. H., Moll, F. L., de Vries, J.-P. P. M., Pasterkamp, G., & de Kleijn, D. P. V. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.190314 · Cited by 102
Self-citationThe Subendothelial Extracellular Matrix Modulates JNK Activation by Flow
Hahn, C., Orr, A. W., Sanders, J. M., Jhaveri, K. A., & Schwartz, M. A. (2009) · Circulation Research · doi:10.1161/circresaha.108.186486 · Cited by 102
Perisic, L., Hedin, E., Razuvaev, A., Lengquist, M., Osterholm, C., Folkersen, L., Gillgren, P., Paulsson-Berne, G., Ponten, F., Odeberg, J., et al. (2013) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.113.301743 · Cited by 97
Self-citationTalusan, P., Bedri, S., Yang, S., Kattapuram, T., Silva, N., Roughley, P. J., & Stone, J. R. (2005) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m500088-mcp200 · Cited by 95
Increased YKL-40 expression in patients with carotid atherosclerosis
Michelsen, A. E., Rathcke, C. N., Skjelland, M., Holm, S., Ranheim, T., Krohg‐Sørensen, K., Klingvall, M. F., Brosstad, F. R., Øie, E., Vestergaard, H., et al. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.02.035 · Cited by 93
Davies, J. D., Carpenter, K. L. H., Challis, I. R., Figg, N. L., McNair, R., Proudfoot, D., Weissberg, P. L., & Shanahan, C. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410075200 · Cited by 86
Self-citationEldrup, N., Grønholdt, M.-L. M., Sillesen, H., & Nordestgaard, B. G. (2006) · Circulation · doi:10.1161/circulationaha.105.593483 · Cited by 80
Elevated plasma YKL‐40 levels and ischemic stroke in the general population
Kjaergaard, A. D., Bojesen, S. E., Johansen, J. S., & Nordestgaard, B. G. (2010) · Annals of Neurology · doi:10.1002/ana.22220 · Cited by 80
Melmer, A., Lamina, C., Tschoner, A., Ress, C., Kaser, S., Laimer, M. W., Sandhofer, A., Paulweber, B., & Ebenbichler, C. F. (2013) · Obesity · doi:10.1002/oby.20289 · Cited by 79
Self-citationTan, C., Liu, Y., Li, W., Deng, F., Liu, X., Wang, X., Gui, Y., Qin, L., Hu, C., & Chen, L. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.11.040 · Cited by 78
Shaked, I., Hanna, D. B., Gleißner, C., Marsh, B. J., Plants, J., Tracy, D., Anastos, K., Cohen, M. H., Golub, E. T., Karim, R., et al. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.303153 · Cited by 77
Cathepsin G Controls Arterial But Not Venular Myeloid Cell Recruitment
Ortega-Gomez, A., Salvermoser, M., Rossaint, J., Pick, R., Brauner, J., Lemnitzer, P., Tilgner, J., de Jong, R. J., Megens, R. T. A., Jamasbi, J., et al. (2016) · Circulation · doi:10.1161/circulationaha.116.024790 · Cited by 74
Chen, F., Eriksson, P. O., Hansson, G. K., Herzfeld, I., Klein, M., Hansson, L., & Valen, G. (2005) · International Journal of Molecular Medicine · doi:10.3892/ijmm.15.1.57 · Cited by 68
LI, W., & YUAN, X. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1329.053 · Cited by 62
Miyamoto, S., Ueda, M., Ikemoto, M., Naruko, T., Ito, A., Tamaki, S., Nohara, R., Terasaki, F., Sasayama, S., & Fujita, M. (2008) · Heart · doi:10.1136/hrt.2007.121640 · Cited by 62
Plasma YKL-40 and Total and Disease-Specific Mortality in the General Population
Johansen, J. S., Bojesen, S. E., Tybjærg‐Hansen, A., Mylin, A. K., Price, P. A., & Nordestgaard, B. G. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2010.146530 · Cited by 62
Ridker, P. M., Chasman, D. I., Rose, L. M., Loscalzo, J., & Elias, J. A. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.114.000897 · Cited by 62
Eisenstein, R., Larsson, S., Kuettner, K. E., Sorgente, N., & Hascall, V. (1975) · Atherosclerosis · doi:10.1016/0021-9150(75)90064-7 · Cited by 60
Kedenko, L., Lamina, C., Kedenko, I., Kollerits, B., Kiesslich, T., Iglseder, B., Kronenberg, F., & Paulweber, B. (2014) · BMC Medical Genetics · doi:10.1186/s12881-014-0112-7 · Cited by 57
Self-citationAbbas, A., Aukrust, P., Dahl, T. B., Bjerkeli, V., Sagen, E. L., Michelsen, A. E., Russell, D., Krohg‐Sørensen, K., Holm, S., Skjelland, M., et al. (2012) · Stroke · doi:10.1161/strokeaha.111.642256 · Cited by 41
Ionita, M. G., Catanzariti, L. M., Bots, M. L., de Vries, J. P. P. M., Moll, F. L., Sze, S. K., Pasterkamp, G., & de Kleijn, D. P. V. (2010) · Stroke · doi:10.1161/strokeaha.110.582122 · Cited by 31
Self-citationProteomics of plaques and novel sources of potential biomarkers for atherosclerosis
Bleijerveld, O. B., Zhang, Y., Beldar, S., Hoefer, I. E., Sze, S. K., Pasterkamp, G., & de Kleijn, D. P. V. (2013) · PROTEOMICS – Clinical Applications · doi:10.1002/prca.201200119 · Cited by 30
Self-citationThe double‐edged sword of fibronectin in atherosclerosis
Moore, K. J., & Fisher, E. A. A. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201200238 · Cited by 30
Rocchiccioli, S., Cecchettini, A., Ucciferri, N., Terreni, M., Viglione, F., Trivella, M. G., Citti, L., Parodi, O., & Pelosi, G. (2015) · Disease Markers · doi:10.1155/2015/465242 · Cited by 12
Cited by
Vascular smooth muscle cells in atherosclerosis
Basatemur, G. L., Jørgensen, H. F., Clarke, M. C. H., Bennett, M. R., & Mallat, Z. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0227-9 · Cited by 1,099
Targeting inflammation in atherosclerosis — from experimental insights to the clinic
Soehnlein, O., & Libby, P. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00198-1 · Cited by 1,019
The Discovery and Development of Liraglutide and Semaglutide
Knudsen, L. B., & Lau, J. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00155 · Cited by 970
Vascular smooth muscle cells in atherosclerosis: time for a re-assessment
Grootaert, M. O. J., & Bennett, M. R. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab046 · Cited by 509
Rakipovski, G., Rolin, B., Nøhr, J., Klewe, I., Frederiksen, K. S., Augustin, R., Hecksher-Sørensen, J., Ingvorsen, C., Polex-Wolf, J., & Knudsen, L. B. (2018) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2018.09.004 · Cited by 509
Metadata
- Authors
- Langley, S. R., Willeit, K., Didangelos, A., Matic, L. P., Skroblin, P., Barallobre-Barreiro, J., Lengquist, M., Rungger, G., Kapustin, A., Kedenko, L., Molenaar, C., Lu, R., Barwari, T., Suna, G., Yin, X., Iglseder, B., Paulweber, B., Willeit, P., Shalhoub, J., Pasterkamp, G., Davies, A. H., Monaco, C., Hedin, U., Shanahan, C. M., Willeit, J., Kiechl, S., & Mayr, M.
- Affiliations
- King's College London (GB)
- Innsbruck Medical University (AT)
- Karolinska Institutet (SE)
- Krankenhaus Bruneck (IT)
- Paracelsus Medical University (AT)
- Imperial College London (GB)
- University Medical Center Utrecht (NL)
- University of Oxford (GB)
- Corresponding author
- Mayr, Manuel
- ORCID
- Langley, Sarah R.
- Willeit, Karin
- Didangelos, Athanasios
- Matic, Ljubica Perisic
- Skroblin, Philipp
- Kapustin, Alexander
- Kedenko, Ludmilla
- Molenaar, Chris
- Barwari, Temo
- Suna, Gonca
- Yin, Xiaoke
- Iglseder, Bernhard
- Paulweber, Bernhard
- Willeit, Peter
- Shalhoub, Joseph
- Pasterkamp, Gerard
- Davies, Alun H.
- Monaco, Claudia
- Hedin, Ulf
- Shanahan, Catherine M.
- Willeit, Johann
- Kiechl, Stefan
- Mayr, Manuel
- Venue
- Journal of Clinical Investigation
- Published
- 2017-03-20
- Volume
- 127
- Issue
- 4
- Pages
- 1546-1560
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC5373893
- OpenAlex
- W2595645464
- Cited by
- 174
- References
- 85
- Citations by year
- 2026: 20 · 2025: 16 · 2024: 26 · 2023: 17 · 2022: 20 · 2021: 18 · 2020: 20 · 2019: 13 · 2018: 13 · 2017: 11
- FWCI
- 12.89
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- Journal of Clinical Investigation (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- National University of Singapore (submittedVersion, cc-by)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- Figshare (submittedVersion, cc-by)
- ORCA Online Research @Cardiff (Cardiff University) (submittedVersion)
- Research Portal (King's College London) (submittedVersion, cc-by)
- Leicester Research Archive (University of Leicester) (submittedVersion, cc-by)
- Spiral (Imperial College London) (submittedVersion, cc-by)
- Funders
- National Institute for Health and Care Research
- British Heart Foundation (FS/13/2/29892, PG/11/46/28979, RG/17/2/32808, CH/16/3/32406, RG/16/14/32397, RG/11/14/29056)
- King's College London
- European Commission
- Austrian Science Fund (J-3679-B13)
- Bundesministerium für Wissenschaft, Forschung und Wirtschaft
- Svenska Sällskapet för Medicinsk Forskning
- Karolinska Institutet
- Stockholms Läns Landsting (ALF‐2011‐0279, ALF‐2011‐0260, ALF2011-0260 and ALF-2011-0279)
- Vetenskapsrådet (349-2007-8703, K2013-65X-06816-30-4, K2009-65X-2233-01-3)
- Österreichische Forschungsförderungsgesellschaft (843536, K-Project Nr. 843536)
- Bundesministerium für Verkehr, Innovation und Technologie
- Novo Nordisk Fonden (NNF15SA0018346)
- Standortagentur Tirol
- Wirtschaftsagentur Wien
- Provincia autonoma di Bolzano - Alto Adige
- Menzies Centre for Australian Studies, King's College London, University of London
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cerebrovascular and Carotid Artery Diseases
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Keywords
- carotid plaque, vulnerable plaque, biomarker signatures, symptomatic carotid disease, MMP-9, S100A8/S100A9, cathepsin D, LGALS3BP, YKL-40, fibronectin, vascular smooth muscle cells, carotid endarterectomy, cardiovascular risk prediction, Bruneck Study
- MeSH terms
- Carotid Artery Diseases, Cells, Cultured, Extracellular Matrix, Female, Humans, Male, Biomarkers, Extracellular Matrix Proteins, Endarterectomy, Carotid, Proteome, Myocytes, Smooth Muscle, Proteomics, Atherosclerosis, Plaque, Atherosclerotic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.